Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD TrialFrans L. Moll, Iris Baumgärtner, Michael R. Jaff et al.|Journal of Endovascular Therapy|2018Cited by 97
A Review of Antithrombotic Therapy and the Rationale and Design of the Randomized Edoxaban in Patients With Peripheral Artery Disease (ePAD) Trial Adding Edoxaban or Clopidogrel to Aspirin After Femoropopliteal Endovascular InterventionMarco J.D. Tangelder, Frans L. Moll, Chuke Nwachuku et al.|Journal of Endovascular Therapy|2015Cited by 19
Characteristics and Lipid Distribution of a Large, High‐Risk, Hypertensive Population: The Lipid‐Lowering Component of the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Vasilios Papademetriou, Gabriel B. Habib, Therese S. Geraci et al.|Journal of Clinical Hypertension|2003Cited by 15